Dietary supplementation with ipriflavone decreases hepatic iron stores in wild type mice

Blood Cells, Molecules, and Diseases

Volumn 60, Issue , 2016, Pages 36-43

  Patchen, Bonnie ^a,b   Koppe, Tiago ^a,b   Cheng, Aaron ^a,b   Seo, Young Ah ^c   Wessling Resnick, Marianne ^c   Fraenkel, Paula G ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Ferroportin; Hemoglobinopathy; Hepcidin; Iron; Thalassemia

Indexed keywords

ERYTHROFERRONE; FERROPORTIN; HEPCIDIN; HORMONE; IPRIFLAVONE; IRON; UNCLASSIFIED DRUG; CATION TRANSPORT PROTEIN; ISOFLAVONE DERIVATIVE; MESSENGER RNA; METAL TRANSPORTING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FOOD COMPOSITION; HEPATIC IRON STORE; INTESTINE; IRON OVERLOAD; IRON STORAGE; LIVER METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SPLEEN; THALASSEMIA INTERMEDIA; WILD TYPE MOUSE; ANIMAL; BETA THALASSEMIA; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; LIVER; METABOLISM; TREATMENT FAILURE;

ANIMALS; BETA-THALASSEMIA; CATION TRANSPORT PROTEINS; DIETARY SUPPLEMENTS; HEPCIDINS; IRON; IRON OVERLOAD; ISOFLAVONES; LIVER; MICE; RNA, MESSENGER; TREATMENT FAILURE;

EID: 84978943534     PISSN: 10799796     EISSN: 10960961     Source Type: Journal    
DOI: 10.1016/j.bcmd.2016.05.004     Document Type: Article

References (24)

1. [1] Rund, D., Rachmilewitz, E., Beta-thalassemia. N. Engl. J. Med. 353:11 (2005), 1135–1146.
2. [2] Gu, X., Zeng, Y., A review of the molecular diagnosis of thalassemia. Hematology 7:4 (2002), 203–209.
3. [3] Borgna-Pignatti, C., et al. Survival and disease complications in thalassemia major. Ann. N. Y. Acad. Sci. 850 (1998), 227–231.
4. [4] Borgna-Pignatti, C., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89:10 (2004), 1187–1193.
5. [5] Gardenghi, S., et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 109:11 (2007), 5027–5035.
6. [6] Papanikolaou, G., et al. Hepcidin in iron overload disorders. Blood 105:10 (2005), 4103–4105.
7. [7] Nicolas, G., et al. Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis. Nat. Genet. 34:1 (2003), 97–101.
8. [8] Ramos, E., et al. Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis. Blood 120:18 (2012), 3829–3836.
9. [9] Cunningham, M.J., et al. Complications of beta-thalassemia major in North America. Blood 104:1 (2004), 34–39.
10. [10] Wood, J.C., et al. The effect of deferasirox on cardiac iron in thalassemia major: impact of total body iron stores. Blood 116:4 (2010), 537–543.
11. [11] Gaun, V., et al. A chemical screen identifies small molecules that regulate hepcidin expression. Blood Cells Mol. Dis. 53:4 (2014), 231–240.
12. [12] Zhen, A.W., et al. The small molecule, genistein, increases hepcidin expression in human hepatocytes. Hepatology 58:4 (2013), 1315–1325.
13. [13] Wu, J., Zhu, Y., Wu, J., Effects of estrogen and estrogenic compounds on cognition in ovariectomized rats. Climacteric 11:3 (2008), 212–220.
14. [14] Zhang, X., et al. Effects of ipriflavone on postmenopausal syndrome and osteoporosis. Gynecol. Endocrinol. 26:2 (2010), 76–80.
15. [15] Delarmelina, J.M., Dutra, J.C., Batitucci Mdo, C., Antimutagenic activity of ipriflavone against the DNA-damage induced by cyclophosphamide in mice. Food Chem. Toxicol. 65 (2014), 140–146.
16. [16] Fraenkel, P.G., et al. Ferroportin1 is required for normal iron cycling in zebrafish. J. Clin. Invest. 115:6 (2005), 1532–1541.
17. [17] Guida, C., et al. A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia. Blood 125:14 (2015), 2265–2275.
18. [18] Albanese, C.V., et al. Ipriflavone directly inhibits osteoclastic activity. Biochem. Biophys. Res. Commun. 199:2 (1994), 930–936.
19. [19] Miyauchi, A., et al. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function. Endocrinology 137:8 (1996), 3544–3550.
20. [20] Yang, Q., et al. 17beta-estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 153:7 (2012), 3170–3178.
21. [21] Kautz, L., et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 46:7 (2014), 678–684.
22. [22] Tsuchiya, H., et al. Suppressive effects of retinoids on iron-induced oxidative stress in the liver. Gastroenterology 136:1 (2009), 341–350 (e8).
23. [23] Anderson, E.R., Xue, X., Shah, Y.M., Intestinal hypoxia-inducible factor-2alpha (HIF-2alpha) is critical for efficient erythropoiesis. J. Biol. Chem. 286:22 (2011), 19533–19540.
24. [24] Wang, F., et al. Normalizing genes for real-time polymerase chain reaction in epithelial and nonepithelial cells of mouse small intestine. Anal. Biochem. 399:2 (2010), 211–217.